Describing and quantifying asthma comorbidity: a population study
Gershon AS, Guan J, Wang C, Victor JC, To T. PLoS One. 2012; 7(5):e34967. Epub 2012 May 7.
Publications
Global asthma prevalence in adults: findings from the cross-sectional world health survey
To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, Boulet LP. BMC Public Health. 2012; 12:204. Epub 2012 Mar 19.
ICES–Métis Nation of Ontario Reports on Chronic Diseases
The course of asthma activity: a population study
Gershon A, Guan J, Victor JC, Wang C, To T. J Allergy Clin Immunol. 2012; 129(3):679-86. Epub 2011 Dec 17.
Pulmonary function testing in the diagnosis of asthma: a population study
Gershon AS, Victor JC, Guan J, Aaron SD, To T. Chest. 2012; 141(5):1190-6. Epub 2011 Oct 26.
Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study
Gershon AS, Warner L, Cascagnette P, Victor JC, To T. Lancet. 2011; 378(9795):991-6. Epub 2011 Sep 10.
Using linked health administrative data to assess the clinical and healthcare system impact of chronic diseases in Ontario
Iron K, Lu H, Manuel D, Henry D, Gershon A. Healthc Q. 2011; 14(3):23-7. Epub 2011 Jul 1.
Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study
Stephenson A, Seitz D, Bell CM, Gruneir A, Gershon AS, Austin PC, Fu L, Anderson GM, Rochon PA, Gill SS. Arch Intern Med. 2011; 171(10):914-20.
Comparison of inhaled long-acting beta-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study
Gershon A, Croxford R, To T, Stanbrook MB, Upshur R, Sanchez-Romeu P, Stukel T. Ann Intern Med. 2011; 154(9):583-92.
The feasibility of COPD surveillance in Ontario: a population study
Victor JC, To T, Wilton A, Guan J, Ho MH, Gershon AS. Healthc Q. 2011; 14(4):25-9.